Announcement on Voluntary Disclosure on Obtaining Notice of Approval for Phase II Clinical Trials of Aikening's New Maintenance Treatment Indications

About this update from Frontier Biotechnologies Inc. Class A

Announcement on Voluntary Disclosure on Obtaining Notice of Approval for Phase II Clinical Trials of Aikening's New Maintenance Treatment Indications The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Frontier Biotechnologies Inc. Class A